Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Defibrotide
Jazz Pharmaceuticals Ireland Limited
Hepatic Veno-Occlusive Disease
2 trials -
Defibrotide
Jazz Pharmaceuticals Ireland Limited
Veno-occlusive Disease
2 trials -
Defibrotide
Jazz Pharmaceuticals Ireland Limited
Severe Hepatic Veno-Occlusive Disease
1 trial -
Depigoid Grass-Mix (1000 DPP/ml), Conjunctival Provocation Test Grass-Mix LETI 30 HEP/ml, The placebo to be used in the clinical trial is the solvent used in the investigational medicinal products’ (IMPs) formulation. The resulting product is a suspension., Depigoid FORTE Grass-Mix (3000 DPP/ml)
Lacuna Pharma Pty Ltd
Allergic rhinoconjunctivitis with or without controlled asthma
1 trial -
Desmopressin
Ferring Pharmaceuticals
Nocturia
1 trial -
Deucravacitinib placebo 3 mg film-coated tablets oral use, Deucravacitinib placebo 6 mg film-coated tablets oral use, deucravacitinib, deucravacitinib
Bristol-Myers Squibb Australia Pty Ltd
Sjogren's syndrome
1 trial -
Diacomit 250 mg hard capsules, Matched Placebo will consist in caspules similar to the 250 and 500 mg capsules of stiripentol but with no active ingredient, Diacomit 500 mg hard capsules
Biocodex
Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)
1 trial -
Diflucan 200mg Hard Capsules, PLACEBO to Posaconazol hexal, Posaconazol HEXAL 100 mg, NOXAFIL® (posaconazole) Injection, Placebo to bactrim, diflucan 200 mg - microcrystalline cellulose capsules, DIFLUCAN INJECTION, REZZAYO 200 mg powder for concentrate for solution for infusion, Saline solution, REZZAYO 200 mg powder for concentrate for solution for infusion, Bactrim Tablets, NOXAFIL® (posaconazole) Delayed-Release Tablets
Mundipharma Pty Limited
Invasive Fungal Diseases in Adults undergoing Allogeneic Blood and Marrow Transplantation (BMT)
1 trial -
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Whooping Cough
1 trial -
Dociparstat
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Dociparstat sodium
Jazz Pharmaceuticals Ireland Limited
Coronavirus Disease 2019 (COVID-19)
1 trial -
Donidalorsen
IONIS PHARMACEUTICALS INC
Hereditary Angioedema (HAE)
1 trial -
Donidalorsen
IONIS PHARMACEUTICALS INC
Hereditary Angioedema
4 trials -
Dordaviprone (ONC201)
Jazz Pharmaceuticals Ireland Limited
H3 K27M
1 trial -
DoriDuo, Mebocaína Anti-Inflam, 1.2 mg + 3 mg, comprimidos para chupar, Placebo to Test and Comparator
Medice Arzneimittel Pütter GmbH & Co. KG
acute pharyngitis
1 trial -
Doripenem
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Ventilator-Associated Pneumonia
1 trial -
Double encapsulated oral transplant of fecal microbiota, Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota
Pari Pharma GmbH
Primary Sclerosing Cholangitis
1 trial -
Double encapsulated oral transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota
Pari Pharma GmbH
Severe Irritable Bowel Syndrome (IBS)
1 trial -
Double-blind 200 mg imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Doxycycline (200mg/day) or Placebo
United Therapeutics Europe Ltd
Persian Gulf Syndrome
1 trial -
Drisapersen
BioMarin Pharmaceutical Australia Pty Ltd
Muscular Dystrophies
2 trials -
Dupilumab, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Neurodermatitis
1 trial -
Dupilumab, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Neurodermatitis
1 trial -
Duvakitug, Matched placebo for test product
Sanofi-aventis Healthcare Pty Ltd
Immune system diseases
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources